Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin
- 1 April 1994
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 22 (1) , 45-50
- https://doi.org/10.1007/bf00431548
Abstract
In order to clarify the characteristics of crystal matrix protein (CMP), which exhibits a remarkable affinity for calcium oxalate crystals and may be important in stone pathogenesis, we have isolated CMP from macromolecular matrix substances of newly-formed calcium oxalate crystals. Purification of CMP consisted of calcium oxalate crystal formation, dissolution of crystals, electrodialysis, anion exchange chromatography and high-performance liquid chromatography. CMP showed the protein band of 31 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The N-terminal amino acid sequence of CMP was identical to that of human prothrombin. Both anti-CMP polyclonal antibody and antihuman prothrombin antibody cross-reacted well with human prothrombin and CMP in Western blotting. Its amino acid composition and its molecular weight of 31 kDa strongly suggest that CMP is the activation peptide of human prothrombin.Keywords
This publication has 20 references indexed in Scilit:
- Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.Proceedings of the National Academy of Sciences, 1992
- Crystal-matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural studyCalcified Tissue International, 1987
- Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.Journal of Clinical Investigation, 1987
- Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.Journal of Clinical Investigation, 1985
- Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombinBiochemistry, 1983
- The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitroClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma.Journal of Clinical Investigation, 1977
- The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi.Journal of Clinical Investigation, 1977
- New method for quantitative determination of uronic acidsAnalytical Biochemistry, 1973